Renalytix

0 followers


Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.

Industries

Headquarters

Stage

Employees

Links

Org chart

James McCullough

Collapse
Thomas McLain
President
Steven Coca
Co-Founder
Michael J. Donovan
Chief Medical Officer
Jed Fulk
Vice President Of Sales
Shelley Glick
Vice President
Nancy Heidman
Director of Quality, Laboratory Control
Anna Flynn
Director, Quality System Compliance And Eh&s
Corey Maxfield
Chief Business Analyst / Strategic Consultant
Elise Wilfinger
Global Head, Marketing & Brand